Camargo Enhances Drug Development Services Through Acquisition of Montreal-based InSymbiosis Read more
Debiopharm and Ipsen Extend Their Strategic Decapeptyl (triptorelin) Partnership for Another 15 Years Read more
Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development Read more
Eton Pharma Announces Licensing of Lamotrigine New Drug Application and Provides Pipeline Update Read more